FI950248A0 - Rokotteita monisoluisia loisia vastaan - Google Patents

Rokotteita monisoluisia loisia vastaan

Info

Publication number
FI950248A0
FI950248A0 FI950248A FI950248A FI950248A0 FI 950248 A0 FI950248 A0 FI 950248A0 FI 950248 A FI950248 A FI 950248A FI 950248 A FI950248 A FI 950248A FI 950248 A0 FI950248 A0 FI 950248A0
Authority
FI
Finland
Prior art keywords
metazoan
parasites
helminth
protective
antigen
Prior art date
Application number
FI950248A
Other languages
English (en)
Swedish (sv)
Other versions
FI950248A (fi
Inventor
William David Smith
Stuart Kevin Smith
Jacqueline Murray
Susan Liddell
David Patrick Knox
Original Assignee
Mallinckrodt Veterinary Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929215505A external-priority patent/GB9215505D0/en
Priority claimed from GB929217635A external-priority patent/GB9217635D0/en
Application filed by Mallinckrodt Veterinary Inc filed Critical Mallinckrodt Veterinary Inc
Publication of FI950248A0 publication Critical patent/FI950248A0/fi
Publication of FI950248A publication Critical patent/FI950248A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/6416Metalloendopeptidases (3.4.24)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
FI950248A 1992-07-21 1995-01-20 Rokotteita monisoluisia loisia vastaan FI950248A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929215505A GB9215505D0 (en) 1992-07-21 1992-07-21 Vaccines
GB929217635A GB9217635D0 (en) 1992-08-19 1992-08-19 Vaccines
PCT/GB1993/001521 WO1994002169A1 (en) 1992-07-21 1993-07-20 Vaccines against metazoan parasites

Publications (2)

Publication Number Publication Date
FI950248A0 true FI950248A0 (fi) 1995-01-20
FI950248A FI950248A (fi) 1995-01-20

Family

ID=26301293

Family Applications (1)

Application Number Title Priority Date Filing Date
FI950248A FI950248A (fi) 1992-07-21 1995-01-20 Rokotteita monisoluisia loisia vastaan

Country Status (20)

Country Link
EP (1) EP0652769B1 (fi)
JP (1) JPH07509698A (fi)
KR (1) KR950702435A (fi)
CN (1) CN1088217A (fi)
AT (1) ATE134878T1 (fi)
AU (1) AU675443B2 (fi)
CA (1) CA2140673A1 (fi)
CZ (1) CZ14495A3 (fi)
DE (1) DE69301733T2 (fi)
ES (1) ES2085163T3 (fi)
FI (1) FI950248A (fi)
HU (1) HUT70985A (fi)
IL (1) IL106407A (fi)
MY (1) MY131433A (fi)
NO (1) NO950211D0 (fi)
NZ (1) NZ254210A (fi)
PL (1) PL307170A1 (fi)
TR (1) TR27329A (fi)
WO (1) WO1994002169A1 (fi)
ZW (1) ZW8893A1 (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9303681D0 (en) * 1993-02-24 1993-04-14 Pitman Moore Inc Vaccines
GB9322702D0 (en) * 1993-11-03 1993-12-22 Agricultural & Food Res Vaccines
AU701642B2 (en) * 1994-03-25 1999-02-04 Mallinckrodt Veterinary, Inc. Vaccines against helminthic parasites
GB9406708D0 (en) * 1994-04-05 1994-05-25 Mallinckrodt Veterinary Inc Vaccines
AU4624997A (en) * 1996-10-10 1998-05-05 Bayer Aktiengesellschaft Nematode proteins, dna sequences coding therefor, their specific antibodies and their use in identifying nematicidal active substances
KR100900837B1 (ko) 2007-12-07 2009-06-04 (주)두비엘 리포펩타이드와 폴리(i:c)를 아쥬반트로 포함하는 강력한백신 조성물
ES2441880B1 (es) * 2012-07-06 2014-11-13 Universidad De Granada Composición basada en polipéptidos para el tratamiento de miasis
CN103014173B (zh) * 2013-01-17 2014-04-16 福建出入境检验检疫局检验检疫技术中心 一种pcr检测鉴定盖罩大蜗牛的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8619293D0 (en) * 1986-08-07 1986-09-17 Munn E A Anthelmintic agents
GB8906156D0 (en) * 1989-03-17 1989-05-04 Munn Edward A Production and use of anthelmintic agents and protective immunogens
US5525508A (en) * 1991-02-06 1996-06-11 Biotech Australia Pty Limited Haemonchus contortus vaccine

Also Published As

Publication number Publication date
EP0652769B1 (en) 1996-03-06
IL106407A0 (en) 1993-11-15
PL307170A1 (en) 1995-05-15
NO950211L (no) 1995-01-20
TR27329A (tr) 1995-01-12
JPH07509698A (ja) 1995-10-26
DE69301733D1 (de) 1996-04-11
EP0652769A1 (en) 1995-05-17
KR950702435A (ko) 1995-07-29
NZ254210A (en) 1996-11-26
AU4579993A (en) 1994-02-14
AU675443B2 (en) 1997-02-06
MY131433A (en) 2007-08-30
HUT70985A (en) 1995-11-28
CA2140673A1 (en) 1994-02-03
ATE134878T1 (de) 1996-03-15
DE69301733T2 (de) 1996-10-31
CN1088217A (zh) 1994-06-22
ES2085163T3 (es) 1996-05-16
FI950248A (fi) 1995-01-20
CZ14495A3 (en) 1995-09-13
HU9500185D0 (en) 1995-03-28
WO1994002169A1 (en) 1994-02-03
ZW8893A1 (en) 1994-06-01
NO950211D0 (no) 1995-01-20
IL106407A (en) 1997-09-30

Similar Documents

Publication Publication Date Title
DK0527760T3 (da) Fremgangsmåder og præparater til vaccination mod HIV
ATE127345T1 (de) Stressproteine und verwendungen dafür.
DE60310562D1 (de) Verfahren zur verstärkung einer immunantwort von nukleinsäureimpfungen
ATE144143T1 (de) Künstlicher impfstoff gegen aids-virus
DE3872754D1 (de) Nachweis von antikoerpern humaner immundefizienz-viren.
NO870476D0 (no) Fremgangsmaate for fremstilling av kryss-beskyttende humane monoklonale antistoffpreparater.
FI950248A0 (fi) Rokotteita monisoluisia loisia vastaan
NZ502144A (en) Multi-subtype FIV vaccines
AU612683B2 (en) Synthetic peptides, antibodies directed against them, and the use thereof
DE3879968D1 (de) Malaria-impfstoff aus copolymerem protein.
ATE72400T1 (de) Kreuzreaktive und schuetzende epitope von circumsporozoit-proteinen.
DE69333111D1 (de) Natürliche menschliche igm antikörper
KR920012116A (ko) 말라리아 항원 hrpii 및 serp의 부분-서열들을 함유하는 보호적 플라스모듐 팔시파룸 하이브리드 단백질, 이의 제조방법 및 이의 용도
DE69433057D1 (de) Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus
KR890008318A (ko) 플라스모듐 팔시파룸의 재조합 히스티딘-고함유 단백질, 이의 제조방법 및 용도
ITRM910385A0 (it) Vaccini utilizzanti eritrociti come veicoli di antigeni.
AR020852A1 (es) Antigenos de vacuna de leptospira para la prevencion de leptospirosis
DK0542895T3 (da) Krydsreaktiv influenza A immunisering
TH14161EX (th) วัคซีน
DK0513565T3 (da) Monoklonale antistoffer mod plasmin-antiplasmin-komplekset, fremgangsmåde til deres fremstilling og deres anvendelse
ES2060162T3 (es) Utilizacion de los anticuerpos monoclonales anti-b2 microglobulina.
ATE143373T1 (de) Proteine, vakzine und nucleinsäuren
TH14161A (th) วัคซีน
BR9711809A (pt) Polipeptìdeo antigênico ou imunogênico, processos para tratar ou prevenir uma doença ou distúrbio em um indivìduo provocado por infecção com htlv-i, e com htlv-ii, para elicitar em um indivìduo a produção de anticorpos que especificamente ligam-se às proteìnas envelopes htlv-ii e htlv-i, e, para gerar uma resposta imune em um indivìduo
TH65071A (th) เพพไทด์ควบคุม และอนุเคราะห์ hiv แอนติเจน องค์ประกอบวัคซีนชุดสำเร็จรูปอิมมูโนแอสเสย์และวิธีการของการตรวจหาแอนติบอดีที่ถูกชักนำโดย hiv